Company intelligence / Profile preview

Rhinomed

Cremorne, Victoria, Australia
Ownership
Private
Development stage
Other
01

Overview

Rhinomed has commercialized multiple Class I nasal medical devices including internal nasal dilators for snoring, sleep and sport (Mute, Turbine) and rhinoswab devices for comfortable, standardized collection of respiratory samples for PCR and rapid antigen testing of viruses such as SARS‑CoV‑2, influenza and RSV, and is developing intranasal drug-delivery applications including INPEAP for mild to moderate sleep apnea, which has completed a pilot Phase 1 trial[2][5][6].

Therapeutic areas
PulmonologyInfectious Diseases
Modalities
DeviceNon-pharmacological therapyDrug delivery device
Industry
Therapeutic Medical Devices
02

Partnerships

BTNX (exclusive Canadian supply agreement for Rhinoswab and Rhinoswab Junior for inclusion in COVID‑19 rapid antigen test kits)[2]SureScreen Australia (exclusive supply agreement for Rhinoswab products in SureScreen’s rapid test range)[6]Victorian Department of Health (purchase order for Rhinoswabs to support COVID‑19 testing capability)[6]NSW Health Pathology (Rhinoswab supply for respiratory testing)[6]AmerisourceBergen (vendor relationship for distribution of Mute in US pharmacies)[5]Cardinal Health / Independence Medical (wholesale distribution for Mute)[5]Symbion / Pharmacy Choice network (Australian pharmacy distribution for Mute)[5]

Beyond the preview

Go deeper on Rhinomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhinomed.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call